World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
114
Citations
68046
World Ranking
4636
National Ranking
2518

Overview

Myron Schwartz is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily focuses on medicine with an emphasis on hepatology, oncology, epidemiology, surgery, and cancer research. The scientist's work explores several main topics, including:

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cancer Immunotherapy and Biomarkers
  • Liver Disease Diagnosis and Treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Hepatitis B Virus Studies
  • Hepatitis C Virus Research
  • Pancreatic and Hepatic Oncology Research

Among the recent papers involving Myron Schwartz are:

  • Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference (2020) published in Hepatology
  • Intratumoral heterogeneity and clonal evolution in liver cancer (2020) published in Nature Communications
  • Intratumoral dendritic cell-CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma (2023) published in Nature Medicine
  • Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma (2024) published in Nature Reviews Clinical Oncology
  • Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020) (2021) published in Gastroenterology

Myron Schwartz has collaborated frequently with several coauthors, including:

  • Parissa Tabrizian (34 publications)
  • Thomas U. Marron (28 publications)
  • Miriam Mérad (24 publications)
  • Josep M. Llovet (21 publications)
  • Maria Isabel Fiel (20 publications)

The scientist's publications have appeared repeatedly in journals such as:

  • Journal of Clinical Oncology (10 publications)
  • Gastroenterology (9 publications)
  • Journal of Hepatology (8 publications)
  • Regular and Young Investigator Award Abstracts (8 publications)
  • HPB (6 publications)

Best Publications

  • Sorafenib in Advanced Hepatocellular Carcinoma

    Josep M. Llovet;Sergio Ricci;Vincenzo Mazzaferro;Philip Hilgard

  • Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

    Vincenzo Mazzaferro;Josep M Llovet;Rosalba Miceli;Sherrie Bhoori

  • Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

    Josep M. Llovet;Adrian M. Di Bisceglie;Jordi Bruix;Barnett S. Kramer

  • Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma

    Yujin Hoshida;Augusto Villanueva;Masahiro Kobayashi;Judit Peix

  • Resection and liver transplantation for hepatocellular carcinoma.

    Josep M. Llovet;Myron Schwartz;Vincenzo Mazzaferro

  • Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study

    Joong Won Park;Minshan Chen;Massimo Colombo;Lewis Rowland Roberts

  • α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma

    Jorge A. Marrero;Ziding Feng;Yinghui Wang;Mindie H. Nguyen

  • Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma

    Augusto Villanueva;Derek Y. Chiang;Pippa Newell;Judit Peix

  • Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features

    Daniela Sia;Yang Jiao;Iris Martinez-Quetglas;Olga Kuchuk;Olga Kuchuk

  • Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma

    Derek Y. Chiang;Augusto Villanueva;Yujin Hoshida;Yujin Hoshida;Judit Peix

  • Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma

    Elisa Wurmbach;Ying Bei Chen;Greg Khitrov;Weijia Zhang

  • Recurrence of Hepatocellular Cancer After Resection: Patterns, Treatments, and Prognosis

    Parissa Tabrizian;Ghalib Jibara;Brian Shrager;Myron Schwartz

  • A System of Classifying Microvascular Invasion to Predict Outcome After Resection in Patients With Hepatocellular Carcinoma

    Sasan Roayaie;Iris N. Blume;Swan N. Thung;Maria Guido

  • The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies.

    Junko Ozao-Choy;Ge Ma;Johnny Kao;George X. Wang

  • Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.

    Daniela Sia;Yujin Hoshida;Augusto Villanueva;Sasan Roayaie

  • Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters

    Sasan Roayaie;Jason S. Frischer;Sukru H. Emre;Thomas M. Fishbein

  • Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline

    Lisa G. Newman;John Waller;Christopher J. Palestro;Myron Schwartz

  • Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis.

    Sasan Roayaie;Jonathan D. Schwartz;Max W. Sung;Sukru H. Emre

  • Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma.

    Augusto Villanueva;Augusto Villanueva;Yujin Hoshida;Yujin Hoshida;Carlo Battiston;Victoria Tovar;Victoria Tovar

  • A Molecular Signature to Discriminate Dysplastic Nodules From Early Hepatocellular Carcinoma in HCV Cirrhosis

    Josep M. Llovet;Yingbei Chen;Elisa Wurmbach;Sasan Roayaie

Frequent Co-Authors

Swan N. Thung
Swan N. Thung Icahn School of Medicine at Mount Sinai
Josep M. Llovet
Josep M. Llovet University of Barcelona
Vincenzo Mazzaferro
Vincenzo Mazzaferro University of Milan
Jordi Bruix
Jordi Bruix University of Barcelona
Yujin Hoshida
Yujin Hoshida The University of Texas Southwestern Medical Center
Scott L. Friedman
Scott L. Friedman Icahn School of Medicine at Mount Sinai
Lewis R. Roberts
Lewis R. Roberts Mayo Clinic
Wan Yee Lau
Wan Yee Lau Chinese University of Hong Kong
Samuel Waxman
Samuel Waxman Icahn School of Medicine at Mount Sinai
Steven H. Itzkowitz
Steven H. Itzkowitz Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA can open doors to a diverse range of healthcare careers. Many students and working professionals seek alternative pathways beyond the traditional MD to quickly enter the healthcare workforce or expand their expertise. For those eager to start their careers sooner, an accelerated lpn program offers a fast-track to becoming a Licensed Practical Nurse, providing essential patient care in a variety of settings.

Mental health is an area of growing demand. If you’re interested in working as a nurse practitioner focused on psychiatry, consider the shortest pmhnp program available online. This option helps you earn specialization faster without compromising quality.

Not everyone in healthcare is directly involved with patient care—administrative roles are just as vital. Explore online healthcare administration programs to prepare for leadership and management positions in hospitals and clinics. If you’re looking for advanced study, discover the cheapest mha programs online healthcare to enhance your qualifications and career prospects affordably.

Best Scientists Citing Myron Schwartz

Trending Scientists

Recently Published Articles